NOTICIAS

Considerations for Complying With 21 CFR 211.110 Guidance for Industry

Considerations for Complying With 21 CFR 211.110 Guidance for Industry

This guidance, when finalized, will describe considerations for complying with the requirements  in 21 CFR 211.110 to ensure batch uniformity and drug product integrity. In addition, this guidance discusses related quality considerations for drug products that are...

New EU rules for health technology assessments become effective

New EU rules for health technology assessments become effective

EMA is ready to support the implementation of the new regulation on health technology assessment (HTAR) (Regulation (EU) 2021/2282) when it becomes applicable on 12 January 2025. The regulation is an important step forward in accelerating and widening access to new...

A common EU approach to data transparency in medicine regulation

A common EU approach to data transparency in medicine regulation

EMA and HMA (Heads of Medicines Agencies) have published a comprehensive overhaul of their guidance on the identification of commercially confidential information (CCI) and personal data in marketing authorisation applications for human medicines. The update reaffirms...

Global Unique Device Identification  Database (GUDID)

Global Unique Device Identification Database (GUDID)

The Food and Drug Administration (FDA) is responsible for protecting the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products, medical devices, the nation’s food supply, cosmetics,...

Embalagens Multilingue

Embalagens Multilingue

Publicado no site  INFARMED   O Infarmed promove e incentiva o uso de embalagens multilingue atendendo à necessidade de garantir o acesso pelos doentes e profissionais de saúde aos medicamentos. Assim o Infarmed convida à consulta das recomendações constantes das...

Implementation of the Regulation on health technology assessment

Implementation of the Regulation on health technology assessment

The Regulation (EU) 2021/2282 on health technology assessment (HTAR) entered into force on 11 January 2022 and will apply from 12 January 2025. In the preparatory phase for the implementation of the HTAR (January 2022 – January 2025), this webpage aims at informing...

Smooth transition to the mandatory use of EUDAMED

Smooth transition to the mandatory use of EUDAMED

In the light of the anticipated go-live of most European database on medical devices (EUDAMED) modules in 2025, MedTech Europe summarises in a position paper the industry viewpoints on the smooth transition to the mandatory use of the European database for medical...

Total Product Lifecycle Considerations for Generative AIEnabled Devices

Total Product Lifecycle Considerations for Generative AIEnabled Devices

While interest in generative artificial intelligence (GenAI) tools across the health care sector has expanded rapidly, there remain open questions on the approach to regulating GenAI-enabled products that may fall within FDA’s jurisdiction, including, but not limited...

Revision of the Cosmetic Products Regulation

Revision of the Cosmetic Products Regulation

Consumers are exposed to chemicals present in cosmetics. Any cosmetic product sold on the EU market must comply with the rules set up by Regulation (EC) No 1223/2009 of the European Parliament and of the Council of 30 November 2009 on cosmetic products (the Cosmetic...

ARTIFICIAL INTELLIGENCE IN MEDICAL DEVICES

ARTIFICIAL INTELLIGENCE IN MEDICAL DEVICES

This questionnaire was prepared in accordance with the request of MDCG, published in the Medical Device Coordination Group (MDCG) position paper in August 2022, for notified bodies to develop common guidance for manufacturers to assist them in the application phase...

First Draft of the General-Purpose AI Code of Practice published

First Draft of the General-Purpose AI Code of Practice published

Independent experts present the first draft of the General-Purpose AI Code of Practice, which will be discussed with around 1000 stakeholders next week. The AI Office is facilitating relevant AI Act understanding with dedicated questions and answers for stakeholders....